Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related CREE
15 Biggest Mid-Day Gainers For Monday
Benzinga's Top Upgrades, Downgrades For May 22, 2017
Related CI
Why You Must Hold Onto Travelers (TRV) in Your Portfolio
5 ETFs & Stocks to Tap At New Heights

Analysts at Sterne Agee downgraded Cree (NASDAQ: CREE) from “buy” to “neutral.” The target price for Cree has been lowered from $66.00 to $59.00. Cree's shares closed at $61.11 yesterday.

Analysts at Jefferies downgraded Cigna (NYSE: CI) from “buy” to “hold.” The target price for Cigna has been lowered from $78.00 to $75.00. Cigna's shares closed at $69.03 yesterday.

Analysts at Stifel Nicolaus downgraded Crimson Exploration (NASDAQ: CXPO) from “buy” to “hold.” The target price for Crimson Exploration is set to $3.75. Crimson Exploration's shares closed at $3.14 yesterday.

Goldman Sachs downgraded AVG Technologies N.V. (NYSE: AVG) from “buy” to “neutral.” The target price for AVG Technologies has been raised from $18.00 to $18.50. AVG Technologies' shares closed at $17.48 yesterday.

Latest Ratings for CREE

DateFirmActionFromTo
May 2017JMP SecuritiesUpgradesMarket PerformMarket Outperform
Apr 2017JP MorganUpgradesNeutralOverweight
Feb 2017JMP SecuritiesDowngradesMarket OutperformMarket Perform

View More Analyst Ratings for CREE
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (CI + AVG)

View Comments and Join the Discussion!